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ABSTRACT
Objectives In rheumatoid arthritis, inadequate cortisol
secretion was observed relative to inﬂammation, but
reasons are unknown. Human adrenal glands cannot be
investigated due to ethical reasons. Thus, a model of
arthritis was studied to test inadequate glucocorticoid
secretion and adrenocortical alterations.
Methods Arthritis in DA rats was induced by collagen
type II. Plasma hormone (cytokine) levels were
determined by ELISA or radioimmunoassay (Luminex).
Adrenocortical cells were investigated making use of in
vitro culture, immunohistochemistry and imaging
techniques, cholesterol uptake studies and electron
microscopical morphological analyses of adrenocortical
lipid droplets and mitochondria.
Results During the course of arthritis, corticosterone
and adrenocorticotropic hormone (ACTH) levels were
only elevated on day 1 after immunisation but were in
the normal range from day 5 to 55. Serum levels of
corticosterone relative to IL-1β were markedly lower in
arthritis than in controls. IL-1β inhibited ACTH-stimulated
corticosterone secretion from adrenocortical cells in vitro.
Cholesterol uptake receptor SR-BI protein was
unchanged. Number of altered swollen and cavitated
mitochondria increased during the course of arthritis
(maximum on day 55), and this was correlated to
reduced breakdown of lipid droplets and increased
Sudan III-positive lipid accumulation from day 28 to 55.
Reduced lipid breakdown measured as a high number of
homogenous lipid droplets negatively correlated with
plasma corticosterone (p=0.022). Adrenocortical tissue
density of normal mitochondria positively correlated with
serum corticosterone levels.
Conclusions This study on inadequate adrenal
glucocorticoid secretion in arthritis demonstrated altered
mitochondria and altered lipid breakdown paralleled by
low corticosterone levels in relation to inﬂammation.
IL-1β is a key cytokine.
INTRODUCTION
Rheumatologists use glucocorticoids in the therapy
of chronic inﬂammatory diseases, and glucocorti-
coids have strong anti-inﬂammatory and antiproli-
ferative effects.1 2 Early studies reported that
decreased adrenocortical function exists in patients
with chronic inﬂammatory diseases such as rheuma-
toid arthritis (RA).3 Similar concepts evolved in
critically ill patients who can develop long-standing
relative adrenal insufﬁciency.4 5 The initial
disposition to believe in the presence of low hypo-
thalamic–pituitary–adrenal (HPA) axis activity
(1950—late 1990s) has been qualiﬁed in human
chronic inﬂammatory diseases.6
One of the most striking ﬁndings was described
as relatively low levels of glucocorticoids in relation
to inﬂammation.7 This can be directly studied
using a hormone-to-cytokine ratio of cortisol and
IL-6 in humans, which demonstrates low levels of
cortisol relative to IL-6 in patients with RA and
reactive arthritis as compared to healthy controls.8
In addition, experimental arthritis in DA rats was
accompanied by relatively low levels of cortico-
sterone relative to inﬂammatory conditions.9
However, the reasons for this phenomenon in RA,
reactive arthritis and experimental arthritis are
still not known.
Several local factors determine generation of glu-
cocorticoids in the adrenal glands: (1) cholesterol
uptake via the high-density lipoprotein (HDL) chol-
esterol scavenger receptor class B member 1
(SR-B1); (2) vacuolar storage and breakdown of
cholesterol via lipases such as the hormone-
sensitive lipase and the adipose triglyceride lipase;
(3) stimulatory factors such as adrenocorticotropic
hormone (ACTH), but also cytokines like IL-1β,
IL-6, TNF or neuropeptides that determine uptake
and steroid conversion; (4) steroid-converting
enzymes and their multiple cofactors that can be
inhibited by TNF and IL-1β; (5) mitochondrial
function because several steroid conversion steps
happen within mitochondria; and (6) secretion of
glucocorticoids. To our knowledge, of these differ-
ent factors, none has been investigated in experi-
mental arthritis.
In particular, the investigation of mitochondria
can be important because these organelles serve ster-
oidogenesis and ATP production in cells of the
adrenal cortex. Mitochondria can undergo marked
ultrastructural changes upon inhibition of important
enzyme steps of steroidogenesis. This has been
demonstrated using aminoglutethimide, a blocker of
the side-chain cleavage enzyme P450scc that con-
verts cholesterol to pregnenolone, a precursor of
glucocorticoids.10 Since inﬂammatory cytokines
such as IL-1β and TNF can similarly interfere with
these important steps of steroidogenesis (reviewed
in ref. 11), one might expect ultrastructural changes
of adrenocortical mitochondria during the course of
inﬂammatory illness.
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In experimental arthritis, we hypothesise that we can observe
(A) inadequate corticosterone secretion in relation to inﬂamma-
tion, (B) a cytokine responsible for inhibition of corticosterone
secretion, (C) a loss of surface expression of SR-B1 and changes
of cholesterol storage/droplets in adrenocortical cells, and (D)
abnormal mitochondria in the course of the disease. This study
included respective parameters to delineate possible adrenocorti-
cal defects in experimental arthritis.
MATERIALS AND METHODS
Animal experiments were conducted according to institutional
and governmental regulations for animal use (Government of
the Oberpfalz AZ 54-2532.1-06/09). Species and vendors are
described in the online supplementary material. Collagen type
II-induced arthritis was induced and scored with standard tech-
niques as given in the online supplementary material.
Corticosterone, ACTH and cytokines (IL-1β and IFNγ) were
measured by radioimmunoassay and ELISA techniques (see
online supplementary material). In vitro superfusion methods
are described in the online supplementary text.
Quantitative analysis of adrenocortical surface SR-B1 expres-
sion was done with the help of immunohistochemistry and
image analysis. Sudan III staining, light microscopy and image
analysis were used to quantify cholesterol storage in adrenocor-
tical cells. Cholesterol uptake into adrenocortical cells was
studied with ﬂuorescent NBD-cholesterol and subsequent FACS
analysis (all techniques described in the online supplementary
material).
Ultrastructural analysis of adrenocortical lipid droplets and
mitochondria was carried out with standard energy-ﬁltered
transmission electron microscopy and image analysis as
described in the online supplementary material. Thereby two
types of lipid droplets were distinguished: (1) smooth lipid dro-
plets that are completely homogenous, and (2) inhomogenous
lipid droplets with vacuolar bodies. Furthermore, electron
micrographs (3150×) were evaluated concerning mitochondria
morphology. To study stimulus-induced changes of lipid morph-
ology, adrenocortical cells were stimulated with either ACTH or
the β-adrenergic agonist isoproterenol, and lipid morphology
was characterised as mentioned in the online supplementary
material.
Statistical analyses were performed by standard techniques,
and a p value below 0.05 was the signiﬁcance level (see online
supplementary material).
RESULTS
Inﬂammation increases adrenal and spleen weight
In order to estimate clinically relevant inﬂammation, we studied
clinical arthritis score and body weight. Arthritis started with
clinical symptoms on days 14–16 (maximum around days 24–26
after immunisation) (ﬁgure 1A). At day 14, body weight
dropped, which continued until days 24–26 (ﬁgure 1B). After
days 24–26, despite maximal arthritis scores, body weight
increased at a similar rate compared with controls (ﬁgure 1B).
Importantly, weight of the adrenal glands already increased
on day 1 after immunisation, but declined to near normal levels
on day 5, indicating an acute response (ﬁgure 1C). However, at
maximal clonal expansion of autoreactive lymphocytes expected
on day 14 (ﬁgure 1C), adrenal weights were high again, and this
remained stable until day 41 (ﬁgure 1C). In the late chronic
phase of the disease, adrenal gland weights became again
normal on day 55 (ﬁgure 1C), which in the light of ongoing
inﬂammation might be a sign of inadequacy.
In contrast, spleen weights increased until day 14 and then
remained stable throughout the entire observation period indi-
cating a continuous immune response (ﬁgure 1D).
Inadequate secretion of HPA axis hormones in relation to
inﬂammation
Parallel to increased adrenal gland weights on day 1, we
observed a marked increase of corticosterone on day 1 (ﬁgure 2A).
However, this normalised on day 5, and despite elevated weights
of adrenal glands between days 14 and 41 and a steadily increasing
IL-1β, corticosterone remained normal (ﬁgure 2A). This remark-
able ﬁnding was similar for plasma levels of ACTH (ﬁgure 2B).
To directly study inadequacy, IL-1β, IL-6, TNF and IFN-γ
were measured in plasma in order to generate a hormone/cyto-
kine ratio. Of these cytokines, only IL-1β demonstrated a con-
tinuous increase over time during the entire course of arthritis
(ﬁgure 2C). IFN-γ increased until day 5 and subsequently
decreased to normal levels (see online supplementary ﬁgure
S1a), which was similar for IL-6 (data not shown). TNF was not
measurable. Thus, IFN-γ and IL-6 are not suitable to demon-
strate inadequacy throughout observation time.
Now, we generated a ratio of plasma corticosterone divided
by plasma IL-1β. Figure 2D shows that this particular ratio was
higher in control animal compared with arthritic animals. A
similar ratio of plasma corticosterone and IFN-γ was generated,
but due to the low levels in the overt phase of arthritis, this
ratio was not suitable to demonstrate inadequacy (see online
supplementary ﬁgure S1b).
Usually, secretion of ACTH is followed by secretion of gluco-
corticoids with a time interval of 15–30 min as known from the
corticotropin-releasing hormone test.12 Thus, one expects that
there exists a positive correlation between plasma ACTH and
serum glucocorticoid levels. Such a positive correlation existed
for plasma ACTH and serum corticosterone in control animals
(see online supplementary ﬁgure S1c) and also for immunised
rats on day 1, the day of maximum corticosterone surge (see
online supplementary ﬁgure S1d). This indicates that ACTH and
corticosterone are coupled in their secretion patterns under
healthy and very early inﬂammatory conditions. However, in
later phases of arthritis, no such positive interrelation existed
(uncoupling, see online supplementary ﬁgure S1e).
IL-1β inhibits ACTH-stimulated secretion of corticosterone
Since IL-1β was a good marker to demonstrate inadequacy, we
tested whether IL-1β can inﬂuence ACTH-stimulated cortico-
sterone secretion from adrenal cells and tissue. Under control con-
ditions without inﬂammation, ACTH stimulated corticosterone
secretion from adrenocortical tissue slices in superfusion chambers
(ﬁgure 2E) and adrenal tissue in culture wells (ﬁgure 2F). This
stimulatory inﬂuence of ACTH was also observed in day 1 immu-
nised animals (ﬁgure 2E), but ACTH was not able to stimulate cor-
ticosterone secretion in late arthritic animals (ﬁgure 2E). Under
control conditions (ﬁgure 2E,F) and on day 1 after immunisation
(ﬁgure 2E), IL-1β inhibited ACTH-stimulated corticosterone secre-
tion. This clearly indicates that IL-1β is a critical inhibitory mol-
ecule that is most probably responsible for inadequacy in DA rats.
Cholesterol uptake and lipid storage in adrenocortical cells
The precursor of glucocorticoid generation is cholesterol ester
that is taken up by adrenocortical cells using the HDL choles-
terol receptor SR-B1.13 14 SR-B1 protein expression did not
differ in controls compared with arthritic animals throughout
the observation phase (ﬁgure 3A).
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We next focused on lipid storage in adrenocortical cells. Lipid
storage was signiﬁcantly increased between controls and arthritic
animals on day 28 (ﬁgure 3B). The lipid storage was also increased
on days 28–55 (combined data) compared with days 5 and 14
(combined data) (ﬁgure 3B). In addition, control values (13.4%
(9.2–17.1)) were not different from combined data of days 5 and
14 (p=0.391) but were lower compared with combined data of
days 28 and 55 (p=0.017). This indicates that from day 28
onwards, despite ongoing inﬂammation, adrenal lipid storage was
higher in experimental arthritis than in controls.
In order to study cholesterol uptake into adrenocortical cells,
the NBD-cholesterol uptake test was applied. NBD cholesterol
uptake was not different in control animals compared with
immunised/arthritic animals throughout the entire observation
period (ﬁgure 3C). In addition, there existed a positive interrela-
tion between NBD cholesterol uptake and serum levels of cor-
ticosterone in control animals but not in immunised/arthritic
animals (ﬁgure 3D), which might be interpreted as uncoupling
of precursor uptake and secreted glucocorticoids.
Characterisation of lipid droplets in adrenocortical cells and
inﬂuence of inﬂammation
Storage of cholesterol in adrenocortical cells happens in lipid
droplets. One can observe two types of lipid droplets, one with
smooth homogenous and one with inhomogenous vacuolar
content (ﬁgure 4A). In order to learn why some droplets are
inhomogenous and others homogenous, we investigated these
droplets in wild-type mice and adipose triglyceride lipase
(ATGL)-deﬁcient mice.15 Most lipid droplets were inhomogen-
ous in wild-type animals, while ATGL-deﬁcient mice do not
possess inhomogenous droplets (ﬁgure 4B). This might indicate
that inhomogenous lipid droplets represent activated lipid dro-
plets that undergo lipid breakdown, and ATGL-deﬁcient animals
cannot breakdown these lipid droplets.
To further characterise morphology of lipid droplets, adreno-
cortical cells isolated from adrenal glands of DA rats were stimu-
lated with ACTH or isoproterenol, which resulted in increased
numbers of inhomogenous lipid droplets and smaller numbers
of homogenous lipid droplets (ﬁgure 4C).
In addition, there was a negative correlation between density
of inhomogenous and homogenous lipid droplets in control and
immunised animals with similar correlation coefﬁcients
(ﬁgure 4D). This physiological part of our studies helped to
characterise two types of lipid droplets, and it also demonstrates
that more inhomogenous lipid droplets are accompanied by less
homogenous lipid droplets and vice versa.
Finally, the number of inhomogenous (homogenous) lipid
droplets was higher (lower) in control animals compared with
Figure 1 Course of clinical arthritis score (A), body weight (B), weight of adrenal glands (C) and spleen weight (D) in experimental arthritis. In all
experiments, at least 6–12 rats were studied at each time point. In panels (A) and (B), data are given as median with 25/75 IQR. The p-value in
panel (B) reﬂects the outcome of a general linear model analysis that compared both experimental groups over all time points. In panels (C) and
(D), the number of rats is given by circular symbols, which sometimes superimpose on each other. The mean value of adrenal weights in controls
amounted to 15.4 mg and of spleens 359 mg. co, control animals (without arthritis). Data in box plots represent the 25th to 75th centiles, the lines
within the boxes represent the median and the lines outside the boxes represent the 10th and 90th centiles.
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immunised animals, which surprisingly indicates reduced lipid
droplet breakdown in immunised animals compared with
control animals (ﬁgure 4E).
Morphology of mitochondria in adrenocortical cells
After breakdown of lipid droplets, released cholesterol is taken
up as cholesteryl ester by mitochondria, which depends on
complex transport mechanisms.16 In mitochondria, steroidogen-
esis is started by the P450scc side chain cleavage enzyme that
converts cholesterol into pregnenolone.
In our studies, we observed normal and altered mitochondria
(ﬁgure 5A). Normal mitochondria demonstrated homogenous
patterns of vesicular structures evenly distributed throughout the
cross section. Altered mitochondria were characterised by swel-
ling, rareﬁcation of cristae/tubuli, more dispersed vesicles in the
matrix, and cavitations within the matrix (ﬁgure 5A). In control
animals, the density of altered mitochondria was six times lower
as compared with the density of normal mitochondria through-
out 55 days (ﬁgure 5B). However, the density of normal mito-
chondria markedly decreased in immunised/arthritic animals
while the density of altered mitochondria signiﬁcantly increased
from day 0 to 55 (ﬁgure 5B). This indicates marked alterations in
mitochondria morphology in experimental arthritis.
Related functional consequences of altered mitochondria
and type of lipid droplets
The density of normal mitochondria positively correlated with
the density of inhomogenous lipid droplets in all animals and in
the subgroup of control animals (ﬁgure 6A). In contrast, the
density of altered mitochondria negatively correlated with the
density of inhomogenous lipid droplets in all animals, and in
the two subgroups of control animals and immunised/arthritic
animals (ﬁgure 6B). This indicates that the presence of normal
mitochondria is related to increased lipid droplet breakdown
while the presence of altered mitochondria is linked to
decreased lipid droplet breakdown.
Although many different factors can inﬂuence serum cortico-
sterone levels such as degradation in tissue such as the liver,
renal elimination and binding to transport proteins, we hypothe-
sised that mitochondria morphology might translate into differ-
ent levels of serum corticosterone. The density of normal
mitochondria was positively correlated to serum corticosterone
levels when using data of all animals (ﬁgure 6C). Due to the
lower number of observations (type II error), this interrelation
was not present in the individual subgroups (ﬁgure 6C). In add-
ition, there was no signiﬁcant interrelation between density of
altered mitochondria and serum corticosterone levels, but the
estimated regression line had a negative slope (ﬁgure 6D).
Finally, the number of homogenous lipid droplets and cor-
ticosterone levels was negatively correlated in immunised/arth-
ritic animals but not in controls (see online supplementary
ﬁgure S2a,b). In addition, a trend towards a positive correlation
was detected between the number of inhomogenous lipid dro-
plets and corticosterone levels in immunised/arthritic animals
but not in controls (see online supplementary ﬁgure S2c,d).
DISCUSSION
This study demonstrated inadequate HPA axis hormone levels
relative to systemic inﬂammation as measured by serum levels of
IL-1β, IL-1β-induced inhibition of ACTH-stimulated
Figure 2 Inadequate secretion of hypothalamic–pituitary–adrenal axis hormones in experimental arthritis. The number of animals in these experiments is
indicated by a circular symbol in the panels (at least n=6). (A) Course of serum corticosterone in controls (co, 100%=238 ng/mL) and immunised/arthritic
animals. (B) Course of plasma adrenocorticotropic hormone (ACTH) in controls (100%=12.1 pg/mL) and immunised/arthritic animals. (C) Plasma IL-1β in
controls (co) and immunised/arthritic rats throughout observation time. (D) Ratio of serum corticosterone divided by serum IL-1β in controls and immunised/
arthritic animals. (E) Inﬂuence of IL-1β on ACTH-stimulated corticosterone secretion. Adrenal tissue slices of control rats (day 0) and immunised/arthritic rats
on day 1, day 28 and day 55 were superfused in the superfusion microchambers in vitro. (F) Inﬂuence of IL-1β on ACTH-stimulated corticosterone secretion
from cultured adrenocortical tissue of normal rats in vitro. Box plots are explained in legend to ﬁgure 1.
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corticosterone secretion from adrenal glands, normal SR-B1
expression throughout illness, increased lipid depots in the later
phase of arthritis compared to control and preclinical phases, a
higher number of altered cavitated mitochondria in experimen-
tal arthritis than in controls and a positive interrelation between
density of normal mitochondria and lipid droplet activation as
well as serum corticosterone.
Relatively inadequate secretion of glucocorticoids but also
ACTH in systemic inﬂammation is a hallmark of chronic inﬂam-
matory diseases in humans,6 7 17–19 but also in animals with
arthritis.9 20 This inadequacy applies not only to patients with
chronic inﬂammatory diseases but also to other inﬂammatory
conditions. For example, a blunted HPA axis response to
repeated IFN-α injections was demonstrated in patients with
myeloproliferative disease over 3 weeks.21 The effect is really
impressive because ACTH and cortisol responses were nearly
blunted.21 In this present study, we were able to conﬁrm rela-
tively low levels of glucocorticoids relative to inﬂammation in
experimental arthritis despite increased weights of adrenal
glands. Increased weights of adrenal glands have been described
earlier in arthritis,20 22 demonstrating a very similar time course
in rats.20
In this study, IL-1β was the marker of inﬂammation because it
was perfectly measurable in rats. While in humans often IL-6 is
used as a maker to demonstrate inadequate secretion of gluco-
corticoids in relation to inﬂammation, the measurable IL-6 is
only a downstream readout parameter of prior IL-1β and TNF
secretion (IL-1β and TNF can hardly be measured in human
serum). However, IL-1β and TNF are most probably the critical
elements that interfere with adrenal steroidogenesis as recently
summarised.11 Fortunately, IL-1β can be measured in rats and,
thus, the ratio of corticosterone/IL-1β is more appropriate to
demonstrate inadequacy than the ratio of cortisol/IL-6. In this
study in rats, neither ratio of corticosterone/IL-6 nor cortico-
sterone/IFN-γ were applicable because both cytokines were not
continuously high and, thus, do not represent a suitable inﬂam-
mation marker.
In earlier theoretical work, we hypothesised that a short rise
and fall of ACTH/cortisol was evolutionarily positively selected
in order to support an early response of but not a long-term
inhibitory inﬂuence on the immune system.23 Such an adaptive
programme would support the described inadequacy. In this
study, an expected immunisation-dependent corticosterone
surge on day 1 in experimental arthritis should be downregu-
lated, which was already observable on day 5. In controls and
day 1 immunised animals, the positive correlation of cortico-
sterone and ACTH levels demonstrates necessary coupling of
the pituitary and adrenal glands, which gets lost in the later
phases. The loss of the ACTH inﬂuence on adrenal glands
during inﬂammation has recently been termed dissociation of
ACTH and glucocorticoids.24 If this theory is correct, regulatory
adaptive mechanisms should be in place that can downregulate
HPA axis activation after an initial inﬂammatory stimulus.
Importantly, IL-1β—our marker of continuous inﬂammation
in the rat—inhibited ACTH-stimulated corticosterone secretion
from adrenocortical cells of normal rats but also from
Figure 3 Cholesterol provision to and uptake in adrenocortical cells during experimental arthritis. The number of animals in these experiments is
indicated by a circular symbol in the panels (at least n=6). Box plots are explained in legend to ﬁgure 1. (A) Expression of the high-density
lipoprotein cholesterol receptor SR-B1 over time. (B) Sudan III positivity (lipid positivity) of adrenocortical cells over time. The p-value stands for the
comparison of all data at days 5/14 with days 28/40/55 in immunised animals (only grey boxes). (C) NBD cholesterol uptake to adrenocortical cells
during the observation period of 55 days. Data are given as median with 25/75 IQR. (D) Interrelation of NBD cholesterol uptake and serum
corticosterone levels. The linear regression lines and Spearman rank correlation coefﬁcients (RRank) are given in the panel.
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superfused adrenal tissue in vitro. In addition, ACTH cannot
stimulate corticosterone secretion in late arthritic adrenal tissue
in culture in vitro. Thus, IL-1β is a perfect candidate for the
unfavourable inﬂuence on the adrenal glands. Similarly, IL-1β
was now described as the critical proinﬂammatory factor in pan-
creatic β-cell destruction in humans with type 2 diabetes melli-
tus as recently demonstrated in randomised clinical trials with
IL-1 receptor antagonist.25 One might speculate that the juvenile
form of arthritis, in which IL-1 receptor antagonist works per-
fectly well, is more dependent on adrenal gland dysfunction
than the adult form of RA.
Among other reasons16 the following important causes for
HPA axis downregulation have been mentioned. (A) The initially
elevated cortisol levels rapidly inhibit hypothalamic neurons
stopping corticotropin-releasing hormone secretion (negative
feedback), but cytokines such as IL-6 may take over adrenal
glucocorticoid stimulation.24 (B) Uptake of HDL cholesterol to
the adrenal gland might be downregulated. (C) Adrenal choles-
terol stores might be emptied so that continuous production of
glucocorticoids is impossible. While there is little doubt that
mechanisms under item A apply for short-lived inﬂammation,
aspects of item B or C have not been investigated in chronic
Figure 4 Characterisation of lipid morphology in the adrenal cortex. Box plots are explained in legend to ﬁgure 1. (A) Electron microscopy
demonstrates homogenous (arrow) and inhomogenous (asterisk) lipid droplets. Magniﬁcation: 3150×. (B) Homogenous and inhomogenous lipid
droplets in wild-type C57BL/6 mice and adipose triglyceride lipase (ATGL)-deﬁcient C57BL/6 mice. ATGL-deﬁcient mice do not possess
inhomogenous lipid droplets. (C) Inﬂuence of adrenocorticotropic hormone (ACTH) and isoproterenol (β-adrenergic agonist) on lipid droplets in
adrenocortical cells from DA rats. Cells were either not stimulated (CO=control) or stimulated with ACTH (ACTH, 10−10 M) or isoproterenol (ISO,
10−6 M). (D) Interrelation between number of inhomogenous and homogenous lipid droplets. The linear regression line of all animals and Spearman
rank correlation coefﬁcients of all, control and experimental animals (RRank) are given. (E) Number of (in-)homogenous lipid droplets in control (co)
versus immunised/arthritic (im) animals. Data are given as means±SEM.
Figure 5 Changes in morphology of
adrenocortical mitochondria during
experimental arthritis. (A) Electron
microscopy demonstrates normal
(arrow) and altered (asterisk)
mitochondria. Magniﬁcation: 3150×.
(B) Course of mitochondrial
morphology in normal (circular
symbols) and immunised/arthritic
animals (triangular symbols).
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inﬂammatory arthritis. It turned out in this study that neither
protein expression of the HDL cholesterol receptor SR-B1 nor
cholesterol uptake were disturbed in experimental arthritis. In
addition, there was no exaggerated emptying of lipid stores as
objectiﬁed by Sudan III staining. Unexpectedly, lipid stores were
even increased in late phase experimental animals as compared
with controls and immunised pre-arthritic animals.
In a recent reﬁnement of the above-given theory, we
expounded that adaptive responses of the body are not positively
selected for a long-lasting inﬂammatory illness.26 27 According to
these theoretical considerations, the chronic inﬂammatory
process starts between around week 6.27 From this point of view,
adaptive responses might be expected until week 6 but not there-
after. Beyond this critical time point, long-standing immune
responses and inﬂammation might lead to unwanted bystander
alterations of the neuroendocrine and other systems.26 For
example, prolonged increase of inﬂammatory stimuli with ele-
vated serum levels of, for example, IL-1β in our study or IFN-α
can diminish the HPA axis responsiveness as described above.21
In addition, longer-term elevated proinﬂammatory cytokines
might inﬂuence steroidogenesis (was suggested, ref. 28). The
question remains how and where steroidogenesis is disturbed.
Since mitochondria in adrenocortical cells are important orga-
nelles for steroidogenesis,16 they became a target of investiga-
tion in this study. It turned out that mitochondria are altered
during the course of experimental arthritis characterised by
swelling, rareﬁcation of cristae/tubuli, more dispersed vesicles in
and cavitations within the matrix. This picture resembles mito-
chondrial alterations when inhibitors of steroidogenesis such as
aminoglutethimide and cyanoketosteroid are administered to
rats.10 29 Aminoglutethimide inhibits the P450scc side chain
cleavage enzyme and cyanoketosteroid inhibits the
3β-hydroxysteroid dehydrogenase; both enzymes can be blocked
by TNF.11 28 Thus, one might speculate that chronic presence
of proinﬂammatory cytokines such as TNF or IL-1β might
change mitochondrial morphology and function. Since the
number of tissue density of intact mitochondria positively corre-
lated with serum corticosterone levels, the presence of altered
mitochondria can be causal for low glucocorticoid generation.
Another marker of normal mitochondria can be breakdown
of lipid droplets in adrenocortical cells because cells with
altered mitochondria might have decreased lipid droplet break-
down. The present study provided an electron microscopic
morphology marker of lipid droplets, which can be separated
in homogenous and inhomogenous. With the help of wild-type
and ATGL-deﬁcient mice, we were able to demonstrate that
lipase-induced breakdown of lipid droplets is related to the
presence of inhomogenous lipid droplets. From this point of
view, inhomogenous droplets might be interpreted as activated
lipid vacuoles that release cholesteryl ester into the cytoplasm,
while homogenous lipid droplets might be interpreted as
homogenous and quiescent fat vacuoles. Importantly, this study
demonstrated that the density of inhomogenous lipid droplets
correlated positively with density of normal mitochondria and
negatively with density of altered mitochondria. In addition,
the number of homogenous (inhomogenous) lipid droplets cor-
related negatively (positively) with plasma corticosterone in
arthritic animals. Both facts support the concept that an
impairment of mitochondria is related to altered lipid break-
down and, probably, steroidogenesis. These ﬁndings support
the higher levels of Sudan III lipid staining in the overt phase
of arthritic illness.
Figure 6 Possible functional consequence of altered mitochondria. In all panels, the linear regression line of all animals and Spearman rank
correlation coefﬁcients (RRank) of all groups are given. (A) and (B) Interrelation of density of normal (A) and altered (B) mitochondria and density of
inhomogenous lipid droplets. (C) and (D) Interrelation between density of normal (C) and altered (D) mitochondria and serum levels of
corticosterone. In all panels, data of animals at different time points during observation were included.
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In conclusion, inadequate secretion of glucocorticoids in rela-
tion to ongoing inﬂammation is visible in long-standing arthritis
(inadequacy). IL-1β inhibits ACTH-stimulated secretion of glu-
cocorticoids. It is accompanied by higher lipid storage in adre-
nocortical cells, altered mitochondrial morphology reminding to
the inﬂuence of chemical steroidogenesis blockers and impaired
lipid droplet breakdown. This study in experimental arthritis is
the ﬁrst to show marked adrenocortical morphological changes
of critical organelles, which is paralleled by inadequate levels of
corticosterone in chronic inﬂammation, and IL-1β seems to be
key cytokine.
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